Literature DB >> 16501108

RNase L plays a role in the antiviral response to West Nile virus.

Svetlana V Scherbik1, Jayashree M Paranjape, Bronislava M Stockman, Robert H Silverman, Margo A Brinton.   

Abstract

Alleles at the Flv locus determine disease outcome after a flavivirus infection in mice. Although comparable numbers of congenic resistant and susceptible mouse embryo fibroblasts (MEFs) are infected by the flavivirus West Nile virus (WNV), resistant MEFs produce approximately 100- to 150-fold lower titers than susceptible ones and flavivirus titers in the brains of resistant and susceptible animals can differ by >10,000-fold. The Flv locus was previously identified as the 2'-5' oligoadenylate synthetase 1b (Oas1b) gene. Oas gene expression is up-regulated by interferon (IFN), and after activation by double-stranded RNA, some mouse synthetases produce 2-5A, which activates latent RNase L to degrade viral and cellular RNAs. To determine whether the lower levels of intracellular flavivirus genomic RNA from resistant mice detected in cells at all times after infection were mediated by RNase L, RNase L activity levels in congenic resistant and susceptible cells were compared. Similar moderate levels of RNase L activation by transfected 2-5A were observed in both types of uninfected cells. After WNV infection, the mRNAs of IFN-beta and three Oas genes were up-regulated to similar levels in both types of cells. However, significant levels of RNase L activity were not detected until 72 h after WNV infection and the patterns of viral RNA cleavage products generated were similar in both types of cells. When RNase L activity was down-regulated in resistant cells via stable expression of a dominant negative RNase L mutant, approximately 5- to 10-times-higher yields of WNV were produced. Similarly, about approximately 5- to 10-times-higher virus yields were produced by susceptible C57BL/6 RNase L-/- cells compared to RNase L+/+ cells that were either left untreated or pretreated with IFN and/or poly(I) . poly(C). The data indicate that WNV genomic RNA is susceptible to RNase L cleavage and that RNase L plays a role in the cellular antiviral response to flaviviruses. The results suggest that RNase L activation is not a major component of the Oas1b-mediated flavivirus resistance phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501108      PMCID: PMC1395436          DOI: 10.1128/JVI.80.6.2987-2999.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection.

Authors:  J Chebath; P Benech; M Revel; M Vigneron
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

2.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

3.  Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture.

Authors:  A Vaheri; W D Sedwick; S A Plotkin; R Maes
Journal:  Virology       Date:  1965-10       Impact factor: 3.616

4.  Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways.

Authors:  A Zhou; J M Paranjape; S D Der; B R Williams; R H Silverman
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

5.  Enzymatic activity of 2'-5'-oligoadenylate synthetase is impaired by specific mutations that affect oligomerization of the protein.

Authors:  A Ghosh; S N Sarkar; W Guo; S Bandyopadhyay; G C Sen
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

Review 6.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews.

Authors:  Hanna Rennert; Dani Bercovich; Ayala Hubert; Dvora Abeliovich; Uri Rozovsky; Anat Bar-Shira; Sonya Soloviov; Letizia Schreiber; Haim Matzkin; Gad Rennert; Luna Kadouri; Tamar Peretz; Yuval Yaron; Avi Orr-Urtreger
Journal:  Am J Hum Genet       Date:  2002-07-23       Impact factor: 11.025

Review 8.  Novel functions of proteins encoded by viral stress-inducible genes.

Authors:  Saumendra N Sarkar; Ganes C Sen
Journal:  Pharmacol Ther       Date:  2004-09       Impact factor: 12.310

9.  Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase.

Authors:  B Dong; L Xu; A Zhou; B A Hassel; X Lee; P F Torrence; R H Silverman
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

10.  INHERITED AND ACQUIRED FACTORS IN RESISTANCE TO INFECTION : I. DEVELOPMENT OF RESISTANT AND SUSCEPTIBLE LINES OF MICE THROUGH SELECTIVE BREEDING.

Authors:  L T Webster
Journal:  J Exp Med       Date:  1933-04-30       Impact factor: 14.307

View more
  78 in total

1.  Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections.

Authors:  Dong Jiang; Jessica M Weidner; Min Qing; Xiao-Ben Pan; Haitao Guo; Chunxiao Xu; Xianchao Zhang; Alex Birk; Jinhong Chang; Pei-Yong Shi; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Virus-induced Ca2+ influx extends survival of west nile virus-infected cells.

Authors:  Svetlana V Scherbik; Margo A Brinton
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

3.  Identification of novel host cell binding partners of Oas1b, the protein conferring resistance to flavivirus-induced disease in mice.

Authors:  S C Courtney; H Di; B M Stockman; H Liu; S V Scherbik; M A Brinton
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 4.  New insights into the role of RNase L in innate immunity.

Authors:  Arindam Chakrabarti; Babal Kant Jha; Robert H Silverman
Journal:  J Interferon Cytokine Res       Date:  2010-12-29       Impact factor: 2.607

5.  Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

6.  Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

Review 7.  Cell-intrinsic innate immune control of West Nile virus infection.

Authors:  Michael S Diamond; Michael Gale
Journal:  Trends Immunol       Date:  2012-06-20       Impact factor: 16.687

8.  Identification of multiple RIG-I-specific pathogen associated molecular patterns within the West Nile virus genome and antigenome.

Authors:  Jennifer German Shipley; Rianna Vandergaast; Lu Deng; Roy A Mariuzza; Brenda L Fredericksen
Journal:  Virology       Date:  2012-07-07       Impact factor: 3.616

9.  Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells.

Authors:  Esther Schnettler; Mark G Sterken; Jason Y Leung; Stefan W Metz; Corinne Geertsema; Rob W Goldbach; Just M Vlak; Alain Kohl; Alexander A Khromykh; Gorben P Pijlman
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 10.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.